Lv65
1790 积分 2022-07-12 加入
Randomized Phase 3 trial demonstrating high efficacy, favourable safety and convenience of a novel calcipotriol and betamethasone dipropionate cream for the treatment of psoriasis
21分钟前
待确认
A Phase 3, Randomized Trial Demonstrating the Improved Efficacy and Patient Acceptability of Fixed Dose Calcipotriene and Betamethasone Dipropionate Cream
2小时前
已完结
Efficacy and safety of topical finasteride spray solution in the treatment of Chinese men with androgenetic alopecia: A phase III, multicenter, randomized, double-blind, placebo-controlled study
23小时前
已完结
Long-term outcomes of IgA nephropathy in China
9天前
已完结
Results of a randomized double-blind placebo-controlled Phase 2 study propose iptacopan as an alternative complement pathway inhibitor for IgA nephropathy
15天前
已完结
Targeted-release budesonide versus placebo in patients with IgA nephropathy (NEFIGAN): a double-blind, randomised, placebo-controlled phase 2b trial
16天前
已完结
Department of Error
16天前
已完结
Results from part A of the multi-center, double-blind, randomized, placebo-controlled NefIgArd trial, which evaluated targeted-release formulation of budesonide for the treatment of primary immunoglobulin A nephropathy
17天前
已完结
Efficacy and Safety of Ravulizumab in IgA Nephropathy
22天前
已完结
Ivarmacitinib for Moderate to Severe Atopic Dermatitis in Adults and Adolescents
30天前
已完结
皖公网安备34019202002308
